Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans
1996

Study of Metalloproteinases in Breast Cancer

Sample size: 37 publication Evidence: moderate

Author Information

Author(s): AE Kossakowska, SA Huchcroft, SJ Urbanski, DR Edwards

Primary Institution: University of Calgary

Hypothesis

The balance between metalloproteinases (MMPs) and their inhibitors (TIMPs) is altered in neoplasia, contributing to the invasive properties of malignant tumors.

Conclusion

The study found that MMP-11 and MMP-9 are associated with malignant breast lesions, allowing for a predictive accuracy of 90% in distinguishing between malignant and benign tissues.

Supporting Evidence

  • MMP-11 distinguished malignant disease with a predictive accuracy of 84%.
  • Detection of either MMP-11 or MMP-9 transcripts increased predictive accuracy to 90%.
  • Elevated MMP-9 and TIMP-1 expression was observed in all four tumor systems studied.

Takeaway

This study looked at how certain proteins in breast tissue can help tell if a tumor is cancerous or not, and found that two specific proteins are really good at this.

Methodology

The study analyzed the expression of MMP and TIMP genes in breast tissue samples using Northern blot analysis.

Limitations

The study focused only on mRNA detection and did not assess protein levels, which may not always reflect mRNA expression.

Participant Demographics

The study included 37 breast tissue samples, comprising benign and malignant lesions.

Statistical Information

P-Value

0.0004

Statistical Significance

p=0.0004

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication